Health ❯Healthcare ❯Clinical Research

Drug Studies

Efficacy Studies Semaglutide Epinephrine Administration Eli Lilly Studies Efficacy of Ubrogepant CGRP Inhibitors Semaglutide Research Human Trials

New Migraine Drug Ubrogepant Shows Promise in Early Symptom Treatment

Recent studies indicate that ubrogepant can significantly reduce migraine-related disability if taken at the first sign of an attack.

FDA Approves Neffy: First Needle-Free Epinephrine Nasal Spray for Allergic Reactions

Semaglutide Drugs Show Potential Beyond Weight Loss

UK Approves Wegovy for Reducing Heart Risks in Overweight Patients